title: Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions.
authors.affiliation: Therapeutic Area Lead, Biocorrection, Drug Safety Research and Development, Pfizer, Andover, Massachusetts 01810, USA.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Leach
authors.forename: Wendy G
authors.initials: WG
authors.lastname: Halpern
authors.forename: Carol W
authors.initials: CW
authors.lastname: Johnson
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Rojko
authors.forename: Tim K
authors.initials: TK
authors.lastname: MacLachlan
authors.forename: Curtis M
authors.initials: CM
authors.lastname: Chan
authors.forename: Elizabeth J
authors.initials: EJ
authors.lastname: Galbreath
authors.forename: Anthony M
authors.initials: AM
authors.lastname: Ndifor
authors.forename: Diann L
authors.initials: DL
authors.lastname: Blanset
authors.forename: Evelyne
authors.initials: E
authors.lastname: Polack
authors.forename: Joy A
authors.initials: JA
authors.lastname: Cavagnaro